相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Fosfomycin Enhances the Active Transport of Tobramycin in Pseudomonas aeruginosa
David L. MacLeod et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Pseudomonas aeruginosa Population Diversity and Turnover in Cystic Fibrosis Chronic Infections
Eilidh Mowat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Differential adaptation of microbial pathogens to airways of patients with cystic fibrosis and chronic obstructive pulmonary disease
Gerd Doering et al.
FEMS MICROBIOLOGY REVIEWS (2011)
The Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Transcription of the Type III Secretion System
Gregory G. Anderson et al.
INFECTION AND IMMUNITY (2010)
Tobramycin and FDA-Approved Iron Chelators Eliminate Pseudomonas aeruginosa Biofilms on Cystic Fibrosis Cells
Sophie Moreau-Marquis et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2009)
Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis
David L. MacLeod et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review
Felix Ratjen et al.
JOURNAL OF CYSTIC FIBROSIS (2009)
The ΔF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability
Sophie Moreau-Marquis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Macrolides as immunomodulatory medications for the therapy of chronic lung diseases
Yolanda S. Lopez-Boado et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Inhibition of airway proteases in cystic fibrosis lung disease
M. Griese et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
In vitro analysis of tobramycin-treated Pseudomonas aeruginosa Biofilms on cystic fibrosis-derived airway epithelial cells
Gregory G. Anderson et al.
INFECTION AND IMMUNITY (2008)
Opportunistic infections in lung disease:: Pseudomonas infections in cystic fibrosis
Marisa I. Gomez et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Transcriptional regulation of the Pseudomonas aeruginosa type III secretion system
Timothy L. Yahr et al.
MOLECULAR MICROBIOLOGY (2006)
Cell wall-inhibitory antibiotics activate the alginate biosynthesis operon in Pseudomonas aeruginosa:: roles of σ22 (AlgT) and the AlgW and Prc proteases
Lynn F. Wood et al.
MOLECULAR MICROBIOLOGY (2006)
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Eric E. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The short apical membrane half-life of rescued ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of ΔF508-CFTR in polarized human airway epithelial cells
A Swiatecka-Urban et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Biofilms and antimicrobial resistance
R Patel
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2005)
A three-component regulatory system regulates biofilm maturation and type III secretion in Pseudomonas aeruginosa
SL Kuchma et al.
JOURNAL OF BACTERIOLOGY (2005)
A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes
HD Kulasekara et al.
MOLECULAR MICROBIOLOGY (2005)
ExoU is a potent intracellular phospholipase
H Sato et al.
MOLECULAR MICROBIOLOGY (2004)
Oxygen limitation contributes to antibiotic tolerance of Pseudomonas aeruginosa in biofilms
G Borriello et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
New concepts of the pathogenesis of cystic fibrosis lung disease
RC Boucher
EUROPEAN RESPIRATORY JOURNAL (2004)
A novel sensor kinase-response regulator hybrid regulates type III secretion and is required for virulence in Pseudomonas aeruginosa
MA Laskowski et al.
MOLECULAR MICROBIOLOGY (2004)
A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa
AL Goodman et al.
DEVELOPMENTAL CELL (2004)
Pathophysiology and management of pulmonary infections in cystic fibrosis
RL Gibson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin
MC Walters et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Pharmacokinetics and bioavailability of aerosolized tobramycin in cystic fibrosis
DE Geller et al.
CHEST (2002)
Isolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting
E Bruscia et al.
GENE THERAPY (2002)
Mechanisms of biofilm resistance to antimicrobial agents
TFC Mah et al.
TRENDS IN MICROBIOLOGY (2001)
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
CK Stover et al.
NATURE (2000)